about
Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disordersUse of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarctionAntemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression.Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.Surviving social assistance: 12-month prevalence of depression in sole-support parents receiving social assistance.Neonatal exposure to fluoxetine and fluvoxamine alteres spine density in mouse hippocampal CA1 pyramidal neurons.Desipramine inhibits histamine H1 receptor-induced Ca2+ signaling in rat hypothalamic cells.Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.Drug interactions: Part I.Chronic subdural hematoma following electro convulsive therapyAssociation of suicide and antidepressant prescription rates in Japan, 1999-2003.Adjuvant analgesics in cancer pain: a review.Desipramine inhibits Na+/H+ exchanger in human submandibular cells.Treatment resistant depression in an Australian context. II: Outcome of a series of patients.Advances in pharmacotherapy: depression in the elderly--issues and advances in treatment.The recognition and treatment of late-life depression: a view from primary care.Therapy with amineptine, a dopamine reuptake inhibitor, in patients with major depressionSelective serotonin reuptake inhibitors.Effects of fluoxetine and imipramine in rat fetuses treated during a critical gestational period: a macro and microscopic study.In vivo and in vitro effect of imipramine and fluoxetine on Na+,K+-ATPase activity in synaptic plasma membranes from the cerebral cortex of rats.Development and Qualification of Physiologically Based Pharmacokinetic Models for Drugs With Atypical Distribution Behavior: A Desipramine Case Study.Fluvoxamine alters the activity of energy metabolism enzymes in the brain.Pharmacokinetics and distribution of fluvoxamine to the brain in rats under oxidative stress.Using Exercise to Ward Off Depression.Depression in a long-term care facility: clinical features and discordance between nursing assessment and patient interviews.Monitoring tricyclic antidepressant therapy.Treatment resistant depression in an Australian context. I: The utility of the term and approaches to management.
P2860
Q28240591-BC976ECD-D4B0-462E-B8D9-BF980DE38B1EQ28345555-D3A57BD9-BD79-42D9-85B9-50D5E12D6309Q33590460-DDAA35B0-ECAC-475F-AF36-68B021E93157Q33677302-654600FE-F13C-4501-9192-CFE88E4E7B80Q34028274-990B1C58-C42A-4547-BEDC-EE6259B84E94Q34566761-819EE780-C829-4A86-92FD-21969C1CB59FQ35918173-34E238CF-298F-421C-AAD7-2B33ACB14676Q36055212-65F8C394-7487-4751-A568-196F4A943BD5Q36138026-A828DFC1-D0AD-4241-BFD9-01C2A5046A6DQ36401031-6AB7D782-1C3A-469E-954D-A7F1378BB09FQ37246336-417878DD-6C8E-4397-A683-4E2AFA0DEC72Q37895398-7CB7FD4F-F6FB-4EB7-9E94-12D23CCE24E3Q40239693-F0BA6191-137A-4C73-84FA-0838CE19F4F0Q40625173-D368E995-42DC-496A-A7DA-D64934525177Q40774661-5A4C7947-A350-44F5-A7E0-570890A1210CQ40957072-8F2C9264-346A-4C65-8720-35532B28EEFBQ41976163-88FF4E9F-E9EA-4E4D-BE9E-B78DE2A66FBAQ42990168-A7973156-35A5-4A68-A54B-5E245C8E6091Q43211986-C2E156F7-EFC9-4AA0-8503-F7D2986EFF39Q43761333-AF372568-6585-46FA-89DB-FE6501E6F9CAQ46018689-7D7F80B4-9DFC-479C-AEDF-2FEAB419C0C4Q48325528-89BC5937-F7A8-4BB6-B4E6-2CC65C4B1550Q48578124-88B183DA-CDA5-44A9-A7FB-D8C7F9C43228Q49619074-8265987E-629E-4A65-81D0-21F3F4925A65Q52013411-019AA9B8-1375-4C87-9EE8-13AC60703157Q52045984-A078FD24-310A-496F-8FCE-987452868EF7Q54213571-32B72C8D-FD0E-4A22-9F4B-99E3CE42062A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The pharmacologic treatment of depression.
@en
type
label
The pharmacologic treatment of depression.
@en
prefLabel
The pharmacologic treatment of depression.
@en
P2093
P1476
The pharmacologic treatment of depression.
@en
P2093
P304
P356
10.1056/NEJM199108293250907
P407
P577
1991-08-01T00:00:00Z